Combined Modality Therapy

"Combined Modality Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used.

Descriptor ID	D003131
MeSH Number(s)	E02.186
Concept/Terms	Combined Modality Therapy Combined Modality Therapy Multimodal Treatment Multimodal Treatments Treatment, Multimodal Treatments, Multimodal Therapy, Combined Modality Combined Modality Therapies Modality Therapies, Combined Modality Therapy, Combined Therapies, Combined Modality

Below are MeSH descriptors whose meaning is more general than "Combined Modality Therapy".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Therapeutics [E02]
Combined Modality Therapy [E02.186]

Below are MeSH descriptors whose meaning is related to "Combined Modality Therapy".

Below are MeSH descriptors whose meaning is more specific than "Combined Modality Therapy".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Combined Modality Therapy" by people in this website by year, and whether "Combined Modality Therapy" was a major or minor topic of these publications.

Bar chart showing 3927 publications over 31 distinct years, with a maximum of 185 publications in 2016

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1991	0	72	72
1992	0	60	60
1993	0	61	61
1994	0	94	94
1995	0	90	90
1996	0	83	83
1997	0	82	82
1998	1	88	89
1999	0	98	98
2000	1	107	108
2001	3	121	124
2002	0	115	115
2003	1	165	166
2004	1	151	152
2005	0	160	160
2006	1	175	176
2007	2	169	171
2008	1	179	180
2009	2	162	164
2010	2	182	184
2011	4	146	150
2012	1	119	120
2013	7	138	145
2014	2	130	132
2015	4	146	150
2016	7	178	185
2017	6	159	165
2018	4	142	146
2019	8	146	154
2020	3	120	123
2021	1	27	28

Below are the most recent publications written about "Combined Modality Therapy" by people in Profiles.

Kawaguchi Y, Hasegawa K, Hagiwara Y, De Bellis M, Famularo S, Panettieri E, Matsuyama Y, Tateishi R, Ichikawa T, Kokudo T, Izumi N, Kubo S, Sakamoto M, Shiina S, Takayama T, Nakashima O, Murakami T, Vauthey JN, Giuliante F, De Carlis L, Romano F, Ruzzenente A, Guglielmi A, Kudo M, Kokudo N. Effect of Diameter and Number of Hepatocellular Carcinomas on Survival After Resection, Transarterial Chemoembolization, and Ablation. Am J Gastroenterol. 2021 08 01; 116(8):1698-1708.

View in: PubMed
Caricchio R, Abbate A, Gordeev I, Meng J, Hsue PY, Neogi T, Arduino R, Fomina D, Bogdanov R, Stepanenko T, Ruiz-Seco P, Gónzalez-García A, Chen Y, Li Y, Whelan S, Noviello S. Effect of Canakinumab vs Placebo on Survival Without Invasive Mechanical Ventilation in Patients Hospitalized With Severe COVID-19: A Randomized Clinical Trial. JAMA. 2021 07 20; 326(3):230-239.

View in: PubMed
Patel RR, He K, Barsoumian HB, Chang JY, Tang C, Verma V, Comeaux N, Chun SG, Gandhi S, Truong MT, Erasmus JJ, Hong DS, Lee PP, Ning MS, Nguyen QN, Heymach JV, Altan M, Blumenschein G, Fossella FV, Sezen D, Chen D, Carter BW, Davies MA, Glitza IC, Diab A, Ferrarotto R, Cabanillas ME, Yuan Y, Shah SJ, Parra ER, Sun B, Cortez MA, Welsh JW. High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: Results of a phase II trial. Radiother Oncol. 2021 09; 162:60-67.

View in: PubMed
Son MBF, Murray N, Friedman K, Young CC, Newhams MM, Feldstein LR, Loftis LL, Tarquinio KM, Singh AR, Heidemann SM, Soma VL, Riggs BJ, Fitzgerald JC, Kong M, Doymaz S, Giuliano JS, Keenaghan MA, Hume JR, Hobbs CV, Schuster JE, Clouser KN, Hall MW, Smith LS, Horwitz SM, Schwartz SP, Irby K, Bradford TT, Maddux AB, Babbitt CJ, Rowan CM, McLaughlin GE, Yager PH, Maamari M, Mack EH, Carroll CL, Montgomery VL, Halasa NB, Cvijanovich NZ, Coates BM, Rose CE, Newburger JW, Patel MM, Randolph AG. Multisystem Inflammatory Syndrome in Children - Initial Therapy and Outcomes. N Engl J Med. 2021 07 01; 385(1):23-34.

View in: PubMed
Barbon CEA, Yao CMKL, Alvarez CP, Goepfert RP, Fuller CD, Lai SY, Gross ND, Hutcheson KA. Dysphagia profiles after primary transoral robotic surgery or radiation for oropharyngeal cancer: A registry analysis. Head Neck. 2021 10; 43(10):2883-2895.

View in: PubMed
Fonseca BO, Possati-Resende JC, Salcedo MP, Schmeler KM, Accorsi GS, Fregnani JHTG, Antoniazzi M, Pantano NP, Santana IVV, Matsushita GM, Dos Reis R. Topical Imiquimod for the Treatment of High-Grade Squamous Intraepithelial Lesions of the Cervix: A Randomized Controlled Trial. Obstet Gynecol. 2021 06 01; 137(6):1043-1053.

View in: PubMed
Hanania HL, Pacha O, Heberton M, Patel AB. Surgical Intervention for Paronychia Induced by Targeted Anticancer Therapies. Dermatol Surg. 2021 06 01; 47(6):775-779.

View in: PubMed
Yechieli RL, Mandeville HC, Hiniker SM, Bernier-Chastagner V, McGovern S, Scarzello G, Wolden S, Cameron A, Breneman J, Fajardo RD, Donaldson SS. Rhabdomyosarcoma. Pediatr Blood Cancer. 2021 05; 68 Suppl 2:e28254.

View in: PubMed
Milgrom SA, Million L, Mandeville H, Safwat A, Ermoian RP, Terezakis S. Non-rhabdomyosarcoma soft-tissue sarcoma. Pediatr Blood Cancer. 2021 05; 68 Suppl 2:e28279.

View in: PubMed
Aaroe AE, Glitza Oliva IC, Al-Zubidi N, Nader ME, Kaya D, Ferguson SD, Wang C, Fuller G, Harrison RA. Pearls & Oy-sters: Primary Pineal Melanoma With Leptomeningeal Carcinomatosis. Neurology. 2021 08 03; 97(5):248-250.

View in: PubMed

People

Explore

Similar Concepts

Top Journals